小野薬品工業 株式会社
Japanese only小野薬品工業 株式会社· Corporate Number: 7120001077374
About this English name
No English name available. Original Japanese name is shown.
Enforcement records (3)
- Oct 5, 2017先駆け審査指定制度対象品目の募集薬事法Ministry of Health, Labour and Welfare
Nivolumab (genetically modified) for biliary tract cancer
- Oct 5, 2017先駆け審査指定制度対象品目の募集Act on Securing Quality, Efficacy and Safety of Pharmaceuticals and Medical DevicesMinistry of Health, Labour and Welfare
The Ministry of Health, Labour and Welfare established the 'Designated Priority Review System' on April 1, 2015, to promote the development of innovative pharmaceuticals, medical devices, regenerative medicine products, and others, aiming for early practical application in Japan.
- Apr 21, 2017Administrative GuidanceAct on Securing Quality, Efficacy and Safety of Pharmaceuticals and Medical DevicesMinistry of Health, Labour and Welfare
Listed the names of pharmaceuticals designated as target items under the Accelerated Review Designation System, along with their intended effects or efficacy and the applicant's name or organization.
Watch this company
Get an email when 小野薬品工業 株式会社 has new enforcement actions or registry changes. Sign-in is via a one-time email link — no password required.
Language
日本語版を見る (Japanese)Registry data
- Corporate Number (法人番号)
- 7120001077374
- Registered address
- 大阪府大阪市中央区道修町２丁目１番５号
- Status
- Active
For compliance use
This profile aggregates public Japanese government records. Always cross-reference the Corporate Number when matching this entity in your systems — Japanese English company names are often inconsistent across sources.